End-stage renal disease (ESRD) patients are vulnerable to Mycobacterium tuberculosis (MTB) infection, but the magnitude of the risk is uncertain. In addition, there is no reliable information on the MTB infection rate of patients undergoing different types of renal replacement therapy (RRT). We used the Taiwan National Health Insurance Research Database to conduct a 9-year nationwide longitudinal study. Among 49 983 ESRD patients who received three renal replacement modalities, there were 562 cases of MTB infection, corresponding to an incidence rate of 3.0 per 1000 patient-years. The risk of MTB infection relative to the general population was 4.5. Multivariate Cox regression analysis indicated that the independent risk factors for MTB infection in ESRD patients are old age (hazard ratio (HR) 1.17 per 10 years, p <0.001), male gender (HR 1.37, p <0.001), silicosis (HR 5.82, p <0.001), and chronic obstructive pulmonary disease (HR 1.68, p 0.012). Hyperlipidaemia (HR 0.71, p <0.001) and hypertension (HR 0.81, p 0.05) are associated with a lower infection rate. There was no effect of RRT modality on MTB infection rate.
Introduction
Mycobacterium tuberculosis (MTB) infection is the deadliest infectious disease worldwide, and is responsible for 1.7 million deaths per year [1] . Although antimicrobial treatment for MTB infection was developed more than 50 years ago, the numbers of MTB cases and deaths continue to increase. Risk factors for MTB infection are often considered to result from impaired host immunity or increased exposure to infection. Age [2] , male gender [3] , malnutrition [4, 5] , human immunodeficiency virus (HIV) infection [6] , silicosis [7, 8] , diabetes mellitus (DM) [9, 10] , glucocorticoids [11] , receipt of transplants [12] [13] [14] , malignancy [15] , low socio-economic status, substance abuse [16] and renal insufficiency [17, 18] are known risk factors for MTB infection. Previous studies indicated that dialysis patients have a 6.9-fold to 52.5-fold higher risk of MTB infection than the general population [17] . Most of these previous studies were cross-sectional single-centre studies that considered only small numbers of patients, and this is presumably the reason for the wide range in estimated relative risk (RR).
Patients with end-stage renal disease (ESRD) are treated with renal replacement therapy (RRT): haemodialysis (HD), peritoneal dialysis (PD), or kidney transplantation. Each of these therapies has the potential to increase the probability of MTB infection. In particular, long-term use of immunosuppressant agents by transplant recipients may increase the risk of infection, long-term attendance at hospital three times a week may increase the MTB transmission rate among HD patients, and peritoneal infection may occur during PD. However, no previous studies have rigorously examined the infection rates of patients given different RRT modalities. Knowledge of the risk of MTB infection following different RRT modalities is clearly very important, especially in MTBepidemic areas. Taiwan has the highest ESRD incidence worldwide, and is also an MTB-epidemic area.
In the current study, we performed a longitudinal cohort study in Taiwan to evaluate the MTB infection rate among ESRD patients. We used the National Health Insurance Research Database (NHIRD) [19] to evaluate the RR of MTB infection in ESRD patients, and compared the hazard ratios for different RRT modalities.
Methods

Data source
This study used data from the NHIRD of Taiwan. In 1995, universal health insurance was initiated in Taiwan, and this covers 99% of the population of 23 million people [20] . In 1999, the Bureau of National Health Insurance began to release all patient data in electronic form under the NHIRD project [19] . Various extracted datasets are available to researchers, and hundreds of published papers have used the NHIRD as the basis for their studies. The NHIRD consists of de-identified secondary data released to the public for research purposes, so the present study was exempt from full review by the Internal Review Board. In this study, we excerpted data from a specially ordered dataset that includes all claim information from patients under the registry of catastrophic illness from January 1996 to December 2006. In Taiwan, patients with ESRD who need long-term RRT can apply for catastrophic illness registration cards from the Bureau of National Health Insurance, so that co-payments are not required for treatment.
Study design
In the current cohort study, all incident ESRD patients in Taiwan from 1 January 1998 to 31 December 2004 were identified from the catastrophic illness dataset. Age, gender, RRT modality, comorbid diseases and the socio-economic status of patients were retrieved from the database. Each patient was followed from the initiation of RRT to the diagnosis of MTB infection, death, withdrawal from the original RRT, or 31 December 2006. For patients who switched dialysis modality or had kidney transplantation during the study period, the two RRT periods were analysed separately.
For comparison of the incidence of MTB infection of our ESRD patients and that of the general population, a longitudinal health insurance dataset of 1 000 000 beneficiaries (randomly sampled from the original NHIRD) was used as a control group. 
Definition of RTTs, MTB infection and comorbidity
PD patients are those with catastrophic illness registration cards for ESRD and insurance claims for PD dialysate. HD patients are those with catastrophic illness registration cards for ESRD and insurance claims for HD treatment for more than 3 months. Kidney transplant recipients are those with catastrophic illness registration cards for kidney transplantation (V42.0) and insurance claims for immunosuppressant agents for more than 3 months. In Taiwan, MTB infection is a legal infectious disease, and the anti-MTB drugs are controlled by a central government health institute. When a doctor diagnoses an incident MTB patient and prescribes anti-tuberculosis (TB) drugs, he or she needs to declare the case to the Taiwan CDC within 1 week. Because it takes 2 months to obtain the TB culture report in clinical practice, we defined an MTB-positive patient as one who had an ICD-9 code (010-018) in at least three ambulatory visits and insurance claims for anti-TB drugs (isoniazid, rifampicin, rifamycin, rifabutin, pyrazinamide, or ethambutol) for more than 90 days. To validate this definition, we use the same criteria in a randomized sample of 1 million, and compared the MTB infection incidence rate with the Taiwan CDC annual report. Hypertension, diabetes and hyperlipidaemia were defined by ICD-9 codes and insurance claims for medication for more than 90 days per year. HIV infection (ICD-9 code 042), silicosis (ICD-9 codes 501-504), chronic obstructive pulmonary disease (COPD) (ICD-9 codes 403, 416, 491-493, 495-495, 508, 515, 516, and 518), connective tissue disease (ICD-9 codes 710, 712, 714, 715, 716, 719, and 728) and malignancy (ICD-9 codes 140-239) were defined by disease codes in at least three ambulatory visits. The monthly salary of beneficiaries was used to indicate economic status.
Statistical analysis
Normally distributed continuous data are expressed as means ± standard deviations. Numerical data with non-normal distributions are expressed as medians and interquartile ranges. For comparison of parameters between different dialysis modalities, the chi-square test was used for categorical variables, and ANOVA and the Mann-Whitney U-test were used for parametric and non-parametric continuous variables, respectively. The incidence of MTB infection was calculated by the Kaplan-Meier method, and compared by use of the log-rank test. Multivariate Cox proportional hazard regression was performed with backward elimination to analyse independent risk factors for MTB infection. Risk factors with p-values <0.1 in univariate Cox analysis were entered into the multivariate analysis. All probabilities were two-tailed. A p-value <0.05 was considered to be significant.
Results
Basic characteristics of the study population After exclusion of patients with coding errors, those who received RRT for <30 days, those who were <20 years in age, those with a history of MTB infection before dialysis and those with age coding errors (seven subjects' birthday are coded as 1800/1/1, or age >120 years), we used the records of 49 983 patients (186 793 patient-year follow-up period) for analysis. Table 1 shows the distribution of gender, comorbid diseases, RRT modality and other characteristics. During the 7year study period, there were slight increases in the annual number of new ESRD cases, mean patient age, and cases of DM, hypertension, and hyperlipidaemia. Table 2 shows the baseline characteristics of patients stratified by RRT modality. Our cohort had 43 495 HD patients (87.0%), 4139 PD patients (8.3%), and 2249 kidney transplantion patients (4.7%). HD patients were the oldest, followed by PD patients, and then kidney transplantion patients (ANOVA, p <0.001). The PD group had the highest percentage of females (p <0.001). The transplantation group had the lowest rate of DM and the highest economic status (p <0.001).
Comparison of MTB infection in the general population and ESRD patients
With use of the same criteria for diagnosis, the MTB infection incidence rate in LHID-2005 was 0.65/1000 patientyears, which is comparable to the 0.67/1000 patient-years that was reported by the Taiwan Centres for Disease [21] . In our ESRD cohort, 562 patients had MTB infections during the study period, corresponding to an incidence rate of 3.0/ 1000 patient-years. Thus, the RR of MTB infection for our ESRD patients is 4.5.
Independent predictors of MTB infection in ESRD patients
During the study period, we identified MTB infection in 562 patients (499 HD patients, 44 PD patients, and 19 kidney transplantion patients). Univariate Cox regression analysis indicated that nine risk factors were significantly associated with MTB infection rate (Table 3 ). In particular, old age, male gender, low socio-economic status, COPD, silicosis and development of ESRD before the year 2001 were associated with an increased MTB infection rate. In contrast, hypertension, hyperlipidaemia and kidney transplantation (Fig. 2) were associated with a lower rate of MTB infection. The Kaplan-Meier plots for each risk factor for MTB infection are illustrated in Fig. 2 .
Multivariate Cox regression analysis indicated that the following variables were independent risk factors for MTB infection: old age, male gender, COPD, silicosis, and [23] [24] [25] [26] , mainly because of the small sizes of these studies. An exception is the cross-sectional study conducted by Chou et al. [27] , which examined Taiwan CDC MTB registration data and indicated an annual MTB infection rate of 24 533 Taiwanese HD patients of 0.5 per 1000 patients in 2001. The other studies only examined 7-38 MTB infection cases from single centres [17] . Thus, the present study is valuable because of the large number of cases and the long follow-up period. The NHIRD contains all medical claim data for Taiwan, allowing a nationwide longitudinal study.
In agreement with previous studies of general populations, we identified old age, male gender, silicosis and COPD as risk factors for MTB infection in ESRD patients. Malnutrition can lead to immune system dysregulation, and is a wellknown risk factor for MTB infection [4] . In the current study, we were unable to measure nutritional parameters, such as body mass index and serum albumin, but we found that hyperlipidaemia and hypertension were protective factors in ESRD patients. Hypertension is common in ESRD patients, unless the patient has heart failure or insufficient effective blood volume. In fact, low blood pressure and low cholesterol are often associated with unfavourable outcomes in ESRD patients [28, 29] . Thus, we believe that hyperlipidaemia and hypertension are indicators of nutritional status in ESRD patients. Diabetes increases the risk of MTB infection in the general population; however, the odds ratio is modest.
A large-scale study that compared 500 000 diabetes patients and 500 000 non-diabetes subjects indicated that the odds ratio of MTB infection was 1.12 [30] . In our analysis, diabetes was not a risk factor for MTB infection in ESRD patients. It is possible that ESRD was such a strong risk factor for MTB infection that it diminished the impact of other risk factors with modest odds ratios. For patients with ESRD, kidney transplantation is considered the best RRT modality in terms of survival and life quality. In the current study, we found that kidney transplantation was associated with a lower MTB infection rate than PD or HD (Fig. 2) , but the transplantation group was also 20 years younger and had better socio-economic status. After multivariate adjustment, we found that kidney transplantation was no longer associated with a lower MTB infection rate.
Since HIV was discovered in the 1980s, the MTB infection rate has increased worldwide, especially in Africa [31] . According to the WHO annual report of 2009, 15% of MTB patients were HIV-positive, one-third of MTB-related deaths were related to concomitant HIV infection, and MTB contributed to 26% of the estimated deaths resulting from HIV infection [1] . In contrast to Western and African countries, the HIV infection rate among MTB patients in Taiwan was only 0.6% in 2007 [22] . In the current study, we only identified eight patients with HIV infection (all in the HD group), but none of them developed MTB infection during the observation period. Thus, HIV infection was not considered in our data analysis.
The current study had several limitations. First, because of the retrospective nature of the study, we did not use the standard procedure for diagnosis of MTB infection (acid-fast stain and culturing). Instead, we diagnosed MTB infection if a patient had taken anti-MTB medication for more than 3 months. It is likely that some patients with MTB infections did not submit claims for medication, or died before 3 months of treatment. Second, it has been reported that half of the MTB infections of ESRD patients are extrapulmonary, especially among PD patients [32, 33] . We were unable to study this issue, because these data were not available in the NHIRD. Third, some possibly important risk factors, such as smoking, nutritional status, intravenous drug abuse, and occupational exposure, are also not available in the NHIRD.
In conclusion, the results of this nationwide longitudinal study indicate that the incidence rate of MTB infection is 3.0/ 1000 patient-years for Taiwanese ESRD patients. As compared with the general population, the RR of MTB infection for ESRD patients is 4.5. The independent risk factors for MTB infection in ESRD patients are older age, male gender, malnutrition, silicosis, and COPD. RRT modality had no affect on the MTB infection rate.
